Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **compounded topical pharmaceutical formulation** combining four active ingredients: - **Ketoprofen** (a non-steroidal anti-inflammatory drug, NSAID) reduces pain and inflammation through inhibition of cyclooxygenase enzymes and prostaglandin synthesis. - **Baclofen** (a muscle relaxant and antispastic agent) acts primarily as a GABA-B receptor agonist, inhibiting spinal reflexes and reducing muscle spasticity or neuropathic pain. - **Amitriptyline** (a tricyclic antidepressant) inhibits reuptake of serotonin and norepinephrine, modulates pain transmission, and reduces neuropathic pain. - **Lidocaine** (a local anesthetic) blocks voltage-gated sodium channels, stabilizing neuronal membranes and reducing peripheral nerve pain. This combination is designed for topical use in the treatment of **chronic localized pain syndromes**—including neuropathic pain and musculoskeletal pain—where conventional therapies have failed or are poorly tolerated. This formulation is custom-compounded in compounding pharmacies; it is not a mass-produced, branded pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ketoprofen + baclofen + amitriptyline + lidocaine.